Finally, we examined whether attenuation of RAD51 could be observed in a non-genetic model of pulmonary arterial hypertension, the Sugen–Hypoxia38-treated rats, and in human patients affected by idiopathic pulmonary arterial hypertension. This evidence concerns the gene RAD51 and pulmonary arterial hypertension.